Multivariate model of progression-free and overall survival
| Variable | HR | 95% CI Lower Bound | 95% CI Upper Bound | P value |
| Multivariate model of progression-free survival | ||||
| Neoadjuvant chemotherapy cycle | <0.001 | |||
| 3 vs 4 | 1.1 | 0.739 | 1.638 | |
| ≥5 vs 4 | 2.196 | 1.45 | 3.325 | |
| BRCA status | 0.006 | |||
| BRCA1/2 mutation vs none | 0.429 | 0.248 | 0.74 | |
| Not test vs no | 0.715 | 0.433 | 1.178 | |
| Complete gross resection | ||||
| Yes vs no | 0.397 | 0.278 | 0.566 | <0.001 |
| Multivariate model of overall survival | ||||
| Neoadjuvant chemotherapy cycle | 0.016 | |||
| 3 vs 4 | 1.606 | 0.797 | 3.237 | |
| ≥5 vs 4 | 2.775 | 1.369 | 5.625 | |
| Histology: high-grade serous vs other | 0.345 | 0.15 | 0.79 | 0.012 |
| Neoadjuvant imaging | ||||
| Response vs none | 1.424 | 0.606 | 3.347 | 0.418 |
| Complete gross resection | ||||
| Yes vs no | 0.398 | 0.227 | 0.699 | 0.001 |